{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:14:14Z","timestamp":1788444854237,"version":"build-2803163510"},"reference-count":29,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"unspecified","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,3,26]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"\n Objectives<\/jats:title>\n This study aimed to investigate the association of the triglyceride-glucose (TyG) index with the risk of acute myocardial infarction (AMI) and all-cause mortality in patients with coronary artery disease (CAD), and to inspect whether AMI mediates the relationship between TyG index and mortality.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n A large-scale, retrospective cohort study.<\/jats:p>\n <\/jats:sec>\n \n Setting<\/jats:title>\n This single-centre study was conducted at a tertiary academic hospital in South China. The association between the TyG index and AMI was assessed using multivariable logistic regression, with progressive adjustment for demographic and clinical covariates. Cox proportional hazards models were used to estimate the HRs for all-cause mortality associated with TyG index. Restricted cubic splines and mediation analysis were employed to examine non-linear relationships and the mediating role of AMI.<\/jats:p>\n <\/jats:sec>\n \n Participants<\/jats:title>\n A total of 20\u2009125 patients diagnosed with CAD during hospitalisation between January 2020 and February 2025 were initially enrolled. After applying exclusion criteria (insufficient data), 18\u2009245 participants were included in the final analysis.<\/jats:p>\n <\/jats:sec>\n \n Outcome measures<\/jats:title>\n We examined the association of the TyG index with the risk of AMI, as well as its association with all-cause mortality across different CAD subgroups.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The association between the TyG index and all-cause mortality was significantly modified by AMI status (P for interaction <0.05). In the fully adjusted model, no significant association was observed in the overall CAD cohort. However, subgroup analysis revealed divergent patterns: among patients without AMI, a modest protective effect was observed (Q3 vs Q1: HR 0.77, 95%\u2009CI 0.63 to 0.94), whereas in those with AMI, the TyG index exhibited a harmful, dose-response relationship with mortality (per-SD increase: HR 1.18, 95%\u2009CI 1.00 to 1.38; Q4 vs Q1: HR 1.60, 95%\u2009CI 1.13 to 2.25). Additionally, each SD increment in the TyG index was associated with 12% higher odds of AMI (OR 1.12, 95%\u2009CI 1.05 to 1.19). Mediation analysis further demonstrated that AMI mediated 9.51% of the total effect of TyG index on mortality (p<0.001).<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n An elevated TyG index independently predicts the risk of AMI in patients with CAD. Its prognostic value for mortality, however, is critically dependent on the presence of AMI: while a higher TyG index is associated with increased mortality in patients with AMI, moderately elevated TyG levels (Q2\u2013Q3) are associated with lower mortality, whereas the highest quartile shows no significant association. Mediation analysis further reveals that AMI significantly mediates the association between TyG index and mortality, highlighting the importance of AMI prevention in mitigating the adverse prognostic impact of insulin resistance in the CAD population. These findings warrant validation in prospective studies.<\/jats:p>\n <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-111404","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T18:00:27Z","timestamp":1781200827000},"page":"e111404","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["The association of triglyceride-glucose index with acute myocardial infarction and all-cause mortality in patients with coronary artery disease stratified by acute myocardial infarction status: a large-scale retrospective cohort study from South China"],"prefix":"10.1136","volume":"16","author":[{"given":"Yanping","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chujuan","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Liang","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry, Shantou University Medical College, Shantou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5756-2085","authenticated-orcid":false,"given":"Ashkan","family":"Rahmati","sequence":"additional","affiliation":[{"name":"Shantou University Medical College, Shantou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0219-4031","authenticated-orcid":false,"given":"Zekai","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songming","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"2026090306262989000_16.6.e111404.1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","article-title":"Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes","volume":"70","author":"Roth","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"2026090306262989000_16.6.e111404.2","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1093\/eurjpc\/zwaa056","article-title":"The cost of coronary heart disease and the promise of prevention","volume":"29","author":"Almarzooq","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2026090306262989000_16.6.e111404.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0358"},{"key":"2026090306262989000_16.6.e111404.4","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"2026090306262989000_16.6.e111404.5","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-019-0982-2","article-title":"Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients","volume":"19","author":"Alizargar","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"2026090306262989000_16.6.e111404.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2016.01.022"},{"key":"2026090306262989000_16.6.e111404.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2011.05.030"},{"key":"2026090306262989000_16.6.e111404.8","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-023-01919-z","article-title":"The triglyceride-glucose index is associated with atherosclerosis in patients with symptomatic coronary artery disease, regardless of diabetes mellitus and hyperlipidaemia","volume":"22","author":"Li","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"2026090306262989000_16.6.e111404.9","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1007\/s44197-024-00269-7","article-title":"Triglyceride-Glucose Index as Predictor for Hypertension, CHD and STROKE Risk among Non-Diabetic Patients: A NHANES Cross-Sectional Study 2001-2020","volume":"14","author":"Sawaf","year":"2024","journal-title":"J Epidemiol Glob Health"},{"key":"2026090306262989000_16.6.e111404.10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12933-022-01615-4","article-title":"Association between triglyceride glucose index, coronary artery calcification and multivessel coronary disease in Chinese patients with acute coronary syndrome","volume":"21","author":"Wang","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"2026090306262989000_16.6.e111404.11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12933-023-01780-0","article-title":"Association of the triglyceride\u2013glucose index with coronary artery disease complexity in patients with acute coronary syndrome","volume":"22","author":"Xiong","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"2026090306262989000_16.6.e111404.12","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-019-0957-3"},{"key":"2026090306262989000_16.6.e111404.13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12933-020-01054-z","article-title":"Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome","volume":"19","author":"Wang","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"2026090306262989000_16.6.e111404.14","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.628109","article-title":"The Triglyceride-Glucose Index, an Insulin Resistance Marker, Was Non-linear Associated With All-Cause and Cardiovascular Mortality in the General Population","volume":"7","author":"Liu","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"2026090306262989000_16.6.e111404.15","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1038\/s41598-019-42700-1","article-title":"Association between insulin resistance, hyperglycemia, and coronary artery disease according to the presence of diabetes","volume":"9","author":"Cho","year":"2019","journal-title":"Sci Rep"},{"key":"2026090306262989000_16.6.e111404.16","first-page":"680","article-title":"Guideline on the diagnosis and treatment of stable coronary artery disease","volume":"46","year":"2018","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"2026090306262989000_16.6.e111404.17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.rec.2018.11.011","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","year":"2019","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"key":"2026090306262989000_16.6.e111404.18","first-page":"359","article-title":"Guideline and consensus for the management of patients with non-ST-elevation acute coronary syndrome (2016)","volume":"45","year":"2017","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"2026090306262989000_16.6.e111404.19","first-page":"766","article-title":"2019 Chinese Society of Cardiology (CSC) guidelines for the diagnosis and management of patients with ST-segment elevation myocardial infarction","volume":"47","year":"2019","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"2026090306262989000_16.6.e111404.20","first-page":"615","article-title":"Guidelines for the management of non-ST elevation acute coronary syndromes (2024)","volume":"52","year":"2024","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"2026090306262989000_16.6.e111404.21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"2026090306262989000_16.6.e111404.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-024-02423-8","article-title":"Triglyceride-glucose index correlates with the occurrence and prognosis of acute myocardial infarction complicated by cardiogenic shock: data from two large cohorts","volume":"23","author":"Liu","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"2026090306262989000_16.6.e111404.23","doi-asserted-by":"publisher","DOI":"10.1093\/EURHEARTJ\/EHZ363"},{"key":"2026090306262989000_16.6.e111404.24","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6891537","article-title":"The Triglyceride-Glucose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome","volume":"2019","author":"Mao","year":"2019","journal-title":"Dis Markers"},{"key":"2026090306262989000_16.6.e111404.25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-079279","article-title":"Association between TyG index and long-term prognosis of patients with ST-segment elevated myocardial infarction undergoing percutaneous coronary intervention: a retrospective cohort study","volume":"14","author":"Zeng","year":"2024","journal-title":"BMJ Open"},{"key":"2026090306262989000_16.6.e111404.26","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-023-02030-z","article-title":"The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001-2018","volume":"22","author":"Zhang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"2026090306262989000_16.6.e111404.27","doi-asserted-by":"crossref","first-page":"16478","DOI":"10.1038\/s41598-023-43512-0","article-title":"Triglyceride glucose index as a predictor of mortality in middle-aged and elderly patients with type 2 diabetes in the US","volume":"13","author":"Zhao","year":"2023","journal-title":"Sci Rep"},{"key":"2026090306262989000_16.6.e111404.28","doi-asserted-by":"publisher","DOI":"10.1042\/CS20000022"},{"key":"2026090306262989000_16.6.e111404.29","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-023-01906-4","article-title":"Triglyceride-glucose index and coronary artery disease: a systematic review and meta-analysis of risk, severity, and prognosis","volume":"22","author":"Liang","year":"2023","journal-title":"Cardiovasc Diabetol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-111404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:27:56Z","timestamp":1788442076000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-111404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,11]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/bmjopen-2025-111404"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-111404","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}